Ascendis

What Ascendis does

Ascendis Health Limited is a South African health and wellness investment holding company, founded in 2008 and listed on the Johannesburg Stock Exchange (ticker: ASC, ISIN: ZAE000185005) from November 2013 until shareholder-approved delisting in November 2025. The company operated two reporting segments: Consumer Health, comprising Ascendis Consumer Brands (vitamins, minerals, supplements and skin care brands such as Solal, Vitaforce, Chela-Fer, Bettaway, Junglevites and Menacal7), Chempure (speciality ingredients distribution for sports nutrition, food and beverage, health and wellness, and personal care), and The Compounding Pharmacy of South Africa (compounded medicines and supplements); and Medical Devices, operating through The Scientific Group (clinical diagnostics, life sciences and point-of-care), Surgical Innovations (surgical and acute care), Ortho-Xact (orthopaedic trauma, reconstruction and sports medicine), and Cardaxes (cardiovascular and respiratory).

The company made money through a mix of consumer branded product sales (OTC, supplements, skin care) across retail, wholesale, pharmacy, hospital, dispensing doctor and direct-selling channels, B2B speciality ingredients distribution through Chempure, and medical device hardware distribution under exclusive agency agreements with multinational OEMs. Pharma-Med brands (Pharmachem, Reuterina, Sinucon, Clonam, Phlexy) were historically distributed through pharmacies, private hospitals, dispensing doctors and government/state tender channels, though the broader Pharma division was divested to Austell Pharma in October 2022 for R215 million.

The business had manufacturing capabilities including a SAHPRA-accredited soft gel capsule facility in Wynberg, Gauteng (one of only two in South Africa) and a GMP-compliant sterile laboratory at The Compounding Pharmacy in Bryanston. The group historically served consumers across Southern Africa, with export presence to 52 countries including the EU, rest of Africa, Middle East and Australia. After amassing debt of nearly R8 billion, Ascendis completed a major group recapitalisation in October 2021, exited Surgical Innovations from business rescue in October 2023, transferred to the JSE General Segment in October 2024, and shareholders approved delisting in November 2025.

Name

Ascendis

Legal name

Ascendis Health Limited

Website

https://ascendishealth.com

Company type

Public

Founded year

2008

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Ascendis Health Limited is a South African health and wellness holding company operating Consumer Health (branded supplements, speciality ingredients, compounding pharmacy) and Medical Devices (exclusive distribution of multinational OEM surgical, diagnostic and orthopaedic equipment) across Southern Africa and export markets.

Ownership category

akta.pro rank

Product category

Health and Wellness Products

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (423450)

SIC

Pharmaceutical Preparations (2834), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Healthy Aging & Cognitive Support Supplements (CRADAGAM)

Keywords

• Consumer healthcare products
• Medical devices distribution
• Pharmaceutical manufacturing
• Health supplements
• Nutraceutical brands

Headquarters

HQ city

Gauteng

HQ country

South Africa

HQ region

Africa

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

1. Consumer Health: Consumer Health comprises three consumer-focused businesses: Ascendis Consumer Brands (health and wellness branded products), Chempure (speciality ingredients), and The Compounding Pharmacy of South Africa (compounded medicines and supplements).
2. Medical Devices: Medical Devices consists of four businesses: The Scientific Group (clinical diagnostics, life sciences and point-of-care), Surgical Innovations (surgical and acute care), Ortho-Xact (orthopaedic trauma and limb, reconstructive and sports medicine), and Cardaxes (cardiovascular and respiratory). These supply surgical, diagnostic and medical equipment under exclusive distribution agreements with major multinational OEMs.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

Core offering

Ascendis Health is a South African healthcare holding company that manufactures, markets and distributes health, wellness and pharmaceutical products through two segments: Consumer Health (branded supplements, vitamins, skin care, compounded medicines, and specialty ingredients via Ascendis Consumer Brands, Chempure, and The Compounding Pharmacy of South Africa) and Medical Devices (exclusive distribution of surgical, diagnostic, orthopaedic, cardiovascular and respiratory equipment from multinational OEMs through The Scientific Group, Surgical Innovations, Ortho-Xact and Cardaxes). It sells to consumers via retail and pharmacies, and to hospitals, dispensing doctors and government via direct sales and tenders.

Product overview

Ascendis Health is a South Africa-based health and wellness investment holding company listed on the Johannesburg Stock Exchange, operating through two main segments: Consumer Health and Medical Devices. Consumer Health comprises four consumer-focused businesses (Ascendis Consumer Brands, Chempure, The Compounding Pharmacy of South Africa, and Supply Chain/manufacturing) offering wellness products, health supplements, specialty ingredients, and compounded medicines. The Consumer Brands portfolio includes acquired brands such as DDL Dental, Bettaway, Chela-Fer, Chela-Mag, Chela-Preg, Junglevites, Menacal7, Solal, SolalSkin, and Vitaforce. Medical Devices operates through four businesses (The Scientific Group, Surgical Innovations, Ortho-Xact, and Cardaxes) distributing surgical, diagnostic, and medical equipment from exclusive distribution agreements with major multinational manufacturers. The Pharma-Med division also markets brands including Pharmachem, Reuterina, Sinucon, Clonam, and Phlexy through pharmacies, hospitals, and government channels. The company also maintains manufacturing capabilities including GMP-accredited facilities in Johannesburg and Wynberg, Gauteng.

Differentiator

Problem solved

Functional benefit

Brands

• DDL Dental: Dental supply company supplying dental materials, instruments and equipment to dental professionals
• Bettaway
• Chela-Fer
• Chela-Mag
• Chela-Preg
• Junglevites
• Menacal7
• Solal
• Solal Skin
• Vitaforce

Products and services

• Ascendis Consumer Brands Health and wellness branded products division within Ascendis Health offering vitamins, minerals, supplements, sports nutrition, effervescents, gummies and skin products to consumers across different segments of the value chain. Distributed via retail, wholesale, pharmacies, hospitals, doctors and direct selling channels locally and internationally.
• Chempure One of sub-Saharan Africa's largest importers and distributors of speciality ingredients used in sports nutrition, food and beverages, health and wellness, and personal care industries. Supplies B2B manufacturer clients across multiple consumer goods categories.
• The Compounding Pharmacy of South Africa Speciality pharmacy that compounds personalised and speciality medication and care products for patients and medical practitioners from premises in Bryanston, Gauteng, featuring a state-of-the-art GMP-compliant sterile laboratory.
• The Scientific Group Medical devices business specialising in clinical diagnostics, life sciences and point-of-care solutions. Distributes imported diagnostic and life science equipment under exclusive OEM agreements with multinational manufacturers.
• Surgical Innovations Medical devices business focused on surgical and acute care, distributing high-end medical devices under exclusive OEM agreements to surgeons and hospitals in South Africa. Exited business rescue in October 2023.
• Ortho-Xact Medical devices business specialising in orthopaedic trauma and limb reconstruction, and sports medicine, distributing imported orthopaedic devices to clinical specialists under exclusive OEM arrangements.
• Cardaxes Medical devices business specialising in cardiovascular and respiratory equipment distribution, supplying imported devices to clinical specialists and healthcare facilities under exclusive OEM agreements.
• DDL Dental Dental supply company supplying dental materials, instruments and equipment to dental professionals across South Africa.
• Bettaway Affordable range of effervescents and gummies designed for everyday, on-the-go use within the Ascendis Consumer Brands portfolio.
• Chela-Fer Chelated iron supplement using amino acid proteins for superior absorption without interaction with nutrients or food. Part of the Arctic Healthcare-acquired portfolio.
• Chela-Preg Complete multi-vitamin and mineral supplement specially formulated for pregnant women containing essential supplements such as iron, calcium and folic acid.
• Junglevites Balanced micronutrient supplement scientifically formulated for children to support optimal growth and active lifestyle.
• Menacal7 Unique formula for development and maintenance of healthy bones, working synergistically with calcium, vitamin D3 and vitamin K2. Acquired with the Arctic Healthcare brand portfolio.
• Solal Healthy aging nutraceutical supplements based on branded raw materials supported by clinical trials for optimum effectiveness. Sits within Ascendis Consumer Brands.
• SolalSkin Compact range of multi-functional skin care products for healthy aging with multiple actives at optimal concentrations.
• Vitaforce Comprehensive nutraceutical brand focused on treating and improving everyday ailments with vitamin, mineral, homeopathic and herbal products. Acquired through the PharmaNatura transaction.

Quantifiable outcome

• Revenue increased by 171% from R598 million to R1.6 billion in FY2014
• +1 more outcomes

Named customers4 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Two partnerships are on record, tiered minor.

• Pharma QminorOthers · 11 February 2026Pharma Q is partly owned by Indian manufacturer Micro Labs. Both Pharma Q and Ascendis are being investigated by South Africa's Competition Commission following a complaint from the health department. The probe is at an early stage regarding alleged collusion in a pharmaceutical tender.
• Sonke (Subsidiary of Sun Pharma)minorOthers · 11 February 2026Sonke is a subsidiary of Indian generic drug maker Sun Pharma. Along with Ascendis and Pharma Q, Sonke is being investigated by South Africa's Competition Commission regarding alleged collusion in a R15.5 billion Aids drug tender.

Scale indicators7 records

Recent moves12 records

Expansion highlights5 records

Broad incumbents

• Aspen Pharmacare Holdings: Largest South African pharmaceutical manufacturer with global reach across generics, specialty, and consumer health. Comparable on the pharmaceutical distribution and South African market footprint, but operates at substantially greater scale and is far more international.
• Clicks Group: Listed South African health and beauty retailer (Clicks and Musica chains) and a major shelf buyer of vitamins, supplements, and OTC products. Comparable as a downstream outlet for Ascendis Consumer Brands and as a competitor in the South African health retail category.
• Dis-Chem Pharmacies: Largest South African specialty pharmacy retailer selling complementary medicines, vitamins, and OTC products into the same end consumers as Ascendis Consumer Brands. While primarily retail rather than brand owner, the overlap in South African supplement/OTC category makes it a relevant channel and category comparable.

Direct peers

• Vital Health Foods: South African contract and branded manufacturer of complementary medicines and supplements, the closest analogue to Ascendis's vertically integrated supplement manufacturing-plus-brands model. Competes in contract manufacturing services similar to those Chempure and the Wynberg facility provide.
• Adcock Ingram Holdings: Listed South African healthcare company with both pharmaceutical (prescription, OTC, generic) and consumer health (personal care, nutraceutical adjacencies) businesses, selling into pharmacies, hospitals, and government channels. Most directly comparable to Ascendis in terms of diversified portfolio and South African route-to-market, although larger and more pharmaceutical-tilted.
• Biogen: South African sports nutrition and wellness brand owner with similar distribution through pharmacies, health shops, and direct selling. Comparable product mix (protein powders, supplements, lifestyle wellness) and similar targeting of consumers seeking preventative health solutions.
• USN (Ultimate Sports Nutrition): South African sports nutrition and supplement brand selling protein, performance, and wellness products through pharmacies, retail, and direct channels. Directly comparable to Ascendis Consumer Brands' Vitaforce, Bettaway, and Chempure-supplied specialty ingredients across sports and lifestyle nutrition.
• Austell Pharmaceuticals: South African pharmaceutical company that acquired Ascendis Pharma in 2022 (R215 million disposal). Holds the bulk of former Ascendis pharmaceutical brands and now competes in the same Pharma-Med wholesale and tender channels Ascendis historically served.
• Cipla (South Africa operations): Indian-headquartered global generic pharmaceutical major with established South African operations (including Cipla Agrimed/Cipla Vet, which Ascendis acquired in 2017). Competes head-to-head in the same tender channels and therapeutic categories as Ascendis Pharma-Med's brands.

Emerging players

• Litha Healthcare Group (M&A Africa / Acino): South African pharmaceutical and consumer health company with operations in pharma distribution, OTC, and complementary medicines across the region. Relevant as a peer in branded pharmaceutical distribution via private hospitals, pharmacy chains, and government channels in Southern Africa.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UC
• LinkedInlinkedin.com/company/ascendis-health

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Subsidiaries9 records

Funding overview

Funding rounds3 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A18 records

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ascendis